Overview

Allogeneic Bone Marrow Transplantation With Matched Unrelated Donors for Patients With Hematologic Malignancies

Status:
Completed
Trial end date:
2007-10-01
Target enrollment:
Participant gender:
Summary
Patients who have cancer of the bone marrow (leukemia) or lymph gland (lymphomas) are being asked to take part in this study. This study uses a new chemotherapy regimen and matched volunteer stem cell transplant to treat patients with cancers of this kind.
Phase:
Phase 2
Details
Lead Sponsor:
Emory University
Treatments:
Busulfan
Cyclophosphamide
Fludarabine
Fludarabine phosphate
Vidarabine